Immunogenicity of nonavalent HPV vaccine administered prior to living donor renal transplantation in adult women: a prospective, single-arm, multi-center clinical trial

Ended Awarded Last action

Contract number
HHSN26100010
Awardee
Awarding agency
Obligated
$1,024,677

Award facts

Opportunity
  • TORFPCC2015 Solicitation number
Contract value 100% obligated
$1,024,676.52 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Chicago, IL 60611, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 · FY26 UDO initiative; immunogenicity of nonavalent HPV vaccine administered prior to living donor renal transplantation in adults: a prospective, single-arm,… -$23,145
Change Order P00002 -$600,325
Change Order 1 $0
Original award $1,648,147

About this award

The National Cancer Institute issued a delivery order to Northwestern University on September 15, 2016, under the Cancer Prevention Agent Development Program 2012–2017 parent IDIQ for a prospective, single-arm, multi-center clinical trial investigating immunogenicity of nonavalent HPV vaccine administered prior to living donor renal transplantation in adult women. The order carries a ceiling value of $1,024,676.52 and is priced on a cost-no-fee basis.

Place of performance is Chicago, IL. Work was scheduled for ultimate completion on September 14, 2023. As of the most recent SCI reporting (FY2022), the order had invoiced $73 thousand across 0.2 FTEs and 402 contractor hours, reflecting a derived government-paid hourly rate of $181.92. Subcontractors performed 100 percent of reported contractor hours in FY2022.

Quick answers

Who was awarded contract HHSN26100010?

HHSN26100010 was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on September 15, 2016.

How much is contract HHSN26100010 worth?

The government has obligated $1,024,677 on HHSN26100010.

Is contract HHSN26100010 an order under another contract?

Yes. HHSN26100010 is a delivery order under HHSN261201200035I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.

Was contract HHSN26100010 competed?

The extent of competition for HHSN26100010 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award